Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles
For example, luteolin (a flavonoid from Chrysanthemum and others) decreased infarct size and improved cardiac function in rat I/R models via Nrf2 activation and HO-1 upregulation (Oyagbemi et al., 2018)
While not FDA-approved in compounded form, your provider can help determine if these treatments are right for you
[DOI] [PubMed] [Google Scholar] 110.Colombo N., Bini S., Miceli D., Bogliun G., Marzorati L., Cavaletti G., Parmigiani F., Venturino P., Tedeschi M., Frattola L., et al
Trubiani, O., Ballerini, P., Murmura, G., Pizzicannella, J., Giuliani, P., Buccella, S., & Caputi, S
"Nobody's minding the store," said Stuart Phillips, a professor of kinesiology at McMaster University in Hamilton